Patent Number |
CA2096159 A1 1993-11-15 |
|
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
|
This invention refers to peptides binding to antibodies that show neutralizing activity against different strains and clinical isolates of HIV-1 and that inhibit the fusion of cells caused by HIV-1.These peptides are applied with an adjuvant, as recombinant fusion proteins, chemically coupled to carrier molecules, as recombinant chimeric viruses or as recombinant antibodies.
|
©Questel
|
|
FamPat family |
Publication Number |
Type |
Publi.Date |
Links |
|
EP0570357 |
A2 |
1993-11-18 |
 |
|
STG: |
(A2) Application published without search report |
|
AP: |
1993EP-0890100 |
|
EP0570357 |
A3 |
1994-04-20 |
 |
|
STG: |
(A3) Published search report |
|
AP: |
1993EP-0890100 |
|
EP0570357 |
B1 |
1997-06-25 |
 |
|
STG: |
(B1) Patent specification |
|
AP: |
1993EP-0890100 |
|
US5693752 |
A |
1997-12-02 |
 |
|
STG: |
(A) Patents Granted before 2001-04-15 |
|
AP: |
1994US-08361479 |
|
US5756674 |
A |
1998-05-26 |
 |
|
STG: |
(A) Patents Granted before 2001-04-15 |
|
AP: |
1995US-08473576 |
|
US5866694 |
A |
1999-02-02 |
 |
|
STG: |
(A) Patents Granted before 2001-04-15 |
|
AP: |
1997US-08843718 |
|
DE570357 |
T1 |
1994-07-28 |
 |
|
STG: |
(T1) Trans. of EP claims (EPTD) |
|
AP: |
1993DE-0890100 |
|
DE69311764 |
D1 |
1997-07-31 |
 |
|
STG: |
(D1) Grant (no unexamined application published) patent law 81 |
|
AP: |
1993DE-6011764 |
|
DE69311764 |
T2 |
1998-02-05 |
 |
|
STG: |
(T2) Trans. of EP patent |
|
AP: |
1993DE-6011764 |
|
JPH06-293797 |
A |
1994-10-21 |
 |
|
STG: |
(A) Published application |
|
AP: |
1993JP-0113007 |
|
JP3369246 |
B2 |
2003-01-20 |
 |
|
STG: |
(B2) Published granted patent (Second level) from 01-03-1996 onwards (Published examined patent application (Second level) 1971-1996) |
|
AP: |
1993JP-0113007 |
|
CA2096159 |
A1 |
1993-11-15 |
 |
|
STG: |
(A1) Application laid open |
|
AP: |
1993CA-2096159 |
|
CA2096159 |
C |
2004-07-20 |
 |
|
STG: |
(C) Patent (second level) |
|
AP: |
1993CA-2096159 |
|
ES2053413 |
T1 |
1994-08-01 |
 |
|
STG: |
(T1) Transl. of the claims with drawings of European applications (former A4) from 1992 |
|
AP: |
1993ES-0890100T |
|
ES2053413 |
T3 |
1997-11-16 |
 |
|
STG: |
(T3) Translation of granted European patent (former B3) |
|
AP: |
1993ES-0890100T |
|
First Date of Grant |
1997-06-25 |
|
1997-12-02 |
|
1998-05-26 |
|
1999-02-02 |
|
1997-07-31 |
|
2003-01-20 |
|
1997-11-16 |
|
2004-07-20 |
Inventor |
KATINGER HERMANN RUEKER FLORIAN HIMMLER GOTTFRIED MUSTER THOMAS PURTSCHER MARTIN MAIWALD GEORG STEINDL FRANZ TRKOLA ALEXANDRA |
All applicant/assignee |
Polymun ScientificImmunbiologische Forschung GmbH ([AT]) Polymun ScientificImmunbiologische Forschung GmbH ([AT]) Polymun ScientificImmunbiologische Forschung GmbH ([AT]) |
|
Katinger Hermann ([AT]) |
|
Katinger Herman ([AT]) |
|
Katinger Hermann ([AT]) |
|
POLIMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNGSGESELLSCHAFT MBH, WIEN, AT |
|
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH, WIEN, AT POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH, WIEN, AT |
|
HERUMAN KATSUTEINGAA |
|
POLIMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNGS GMBH POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH |
|
KATINGER, HERMANN RUKER, FLORIAN HIMMLER, GOTTFRIED MUSTER, THOMAS TRKOLA, ALEXANDRA PURTSCHER, MARTIN MAIWALD, GEORG STEINDL, FRANZ KATINGER, HERMANN ([AT]) |
Priority Details |
1992AT-0000987 1992-05-141992US-07932787 1992-08-291994US-08361479 1994-12-221995US-08473576 1995-06-071997US-08843718 1997-04-17 |
Designated States |
Contracting States: BE CH DE DK ES FR GB IE IT LI NL PT SE |
|
|
©Questel
|